ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Benchmarking Initiative to Reduce Bronchopulmonary Dysplasia

This study is ongoing, but not recruiting participants.
Study NCT00067613.   Last updated on June 23, 2005.   Information provided by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  Benchmarking Initiative to Reduce Bronchopulmonary Dysplasia
Official Title  A Randomized Controlled Trial of Benchmarking to Reduce Bronchopulmonary Dysplasia
Brief Summary

Premature infants may develop bronchopulmonary dysplasia (BPD), a type of chronic lung disease. The type of care that a premature infant receives in a neonatal intensive care unit (NICU) may affect whether the infant will develop BPD. This study will compare care practices between different NICUs to see which practices prevent BPD. The study will then create, administer, and evaluate a program designed to improve care practices in NICUs.

Detailed Description

Although survival of very low birth weight (VLBW, <1500 g) infants has improved, many of these infants sustain chronic lung injury that is a significant health burden. Previous studies within the NICHD Neonatal Research Network have shown substantial differences in the incidence of BPD between centers. These differences were not explained by birth weight, gestational age, race, frequency of antenatal steroid use, or incidence of respiratory distress syndrome. Practice differences may contribute to BPD incidence variation. This study will evaluate the efficacy of a Benchmarking Initiative to modify clinical care practices and decrease incidence of BPD in VLBW infants.

Benchmarking is a method involving detailed comparisons of processes between similar organizations. For this study, three Network centers with the lowest rates of BPD have been identified as benchmark centers. During a 6-month pre-intervention period, details of care practices and management style at these three centers will be carefully assessed. The baseline rate of BPD at each center will be measured for a 1-year period using a physiologic definition of BPD designed for this study. This definition of BPD is based on a measurement of room air oxygen saturation.

After the pre-intervention period, 14 study sites within the Network will be randomized to either the benchmarking intervention or usual care practices. The benchmarking intervention will consist of data feedback, training in continuous quality improvement techniques, evidence review, site visits to the 3 benchmark centers, and identification of practice changes. The intervention will last 1 year. Change in rate of survival without BPD at 36 weeks corrected age will be compared between the intervention sites and the control sites. The rate of BPD at each site in the post-intervention period will also be compared to its pre-intervention rate.

Study Phase
Study Type  Interventional
Study Design  Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Primary Outcome Measure 
Secondary Outcome Measure 
Condition  Bronchopulmonary Dysplasia
Intervention  Device: ventilation strategies
Drug: steroid therapy
Drug: surfactant therapy
Drug: drug strategies
Device: device strategies
MEDLINE PMIDs
Links Click here for more information about the Neonatal Research Network. This link exits the ClinicalTrials.gov site
Recruitment Information Fields
Recruitment Status  Active, not recruiting
Enrollment  8500
Start Date  March 2001
Completion Date August 2004
Eligibility Criteria 

Inclusion Criteria

  • Infants born at participating center
  • Birthweight of 501 to 1249 grams (1.1 to 2.75 lbs.)

Exclusion Criteria

  • Diagnosed with a syndrome as defined by the Neonatal Research Network’s Generic Database Study
Gender Both
Ages
Accepts Healthy Volunteers No
Contacts ††
Location Countries  United States
Administrative Information Fields
NCT ID  NCT00067613
Organization ID 2U10HD021364
Secondary IDs ††
Study Sponsor  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborators ††
Investigators 
Principal Investigator:     Michele Walsh-Sukys, MD     Case Western Reserve University    
Information Provided By Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Verification Date September 2004
First Received Date  August 25, 2003
Last Updated Date June 23, 2005

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers